The Department of Defense is issuing a Request for Quotation to obtain quotes for specific pharmaceutical agents to be considered for its Uniform Formulary. The Pharmacy and Therapeutics Committee will review six newly approved drugs, including Hyrnuo and Starjemza, for a meeting in February 2026. The agency may award blanket purchase and discount program agreements based on the formulary decisions. A pre-quotation teleconference is scheduled for December 17, 2025. Clinical question responses must be submitted via email by a deadline specified within the solicitation documents.